May, Million Prescriptions: What we know about the growing use of prescription opioids in Ontario. Technical Appendix

Similar documents
Narcotics Monitoring System (NMS) Update

2017 Alberta Triplicate Prescription Program Atlas

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference

OPIOID PRESCRIBING BY ONTARIO DENTISTS

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

Alberta Health. Opioids and Substances of Misuse Alberta Report, 2016 Q4

Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch

NACRS ED reporting for opioid overdose

PRESCRIPTION DRUG MONITORING PROGRAM

Starting on Opioids. Health Quality Ontario

USE OF OPIODS AT HIGHER DOSES IN PERSONS WITHOUT CANCER: MORPHINE EQUIVALENT DOSE EDIT

Alberta Health. Opioids and Substances of Misuse. Alberta Report, 2017 Q3

Abuse, Misuse, and Diversion of Prescription Opioids: Evaluating the Problem and Proposed Solutions

Proposed Changes to Existing Measure for HEDIS : Use of Opioids at High Dosage (UOD)

Opioids in Peel: A Profile of Opioid Use and Related Harms

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

Clinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid

Supplementary Online Content

The Morbidity and Mortality of Kansas Drug Epidemic

Opiate Use among Ohio Medicaid Recipients

Ontario s Narcotics Strategy

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

Looking for Balance: Antipsychotic medication use in Ontario long-term care homes. Technical Appendix

Screening - inclusion criteria

Opioid Addiction Statistics

Alberta Health. Opioids and Substances of Misuse. Alberta Report, 2017 Q2

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Opioid and Other Substance Misuse

Screening - inclusion criteria

STARTER PACK: Webinar #1 ADE4 - OPIOIDS

Tamper-Resistant Properties of Drugs Regulations (TRPDR)

Understanding the STOP Act s 5- and 7-day prescribing limits

Diversion, Misuse and Trafficking of Methadone and Buprenorphine in the US and Europ

Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.

HOW DOES THE STOP ACT IMPACT YOU?

MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111

Mindful Prescribing for Acute Pain

The Latest Prescription Trends for Controlled Prescription Drugs

Cigna Drug and Biologic Coverage Policy

Nalbuphine morphine cross reactivity

See Important Reminder at the end of this policy for important regulatory and legal information.

Diversion, misuse and trafficking of methadone and buprenorphine

Pharmaceutical Misuse and its Challenges: Opioid Use in Ontario. Ontario Harm Reduction Conference Tara Gomes Tuesday January 31, 2012

As Introduced. 132nd General Assembly Regular Session H. B. No Representative Ramos Cosponsors: Representatives Seitz, Fedor, Ashford

See Important Reminder at the end of this policy for important regulatory and legal information.

Opioid Prescribing for Acute Pain

Atlas of Healthcare Variation

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Arkansas Department of Health

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Lorzone (chlorzoxazone) dose, indications, adverse effects, interactions... from PDR.net

Increase in Opioid Related Deaths What the Data Can Tell us. Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes

CLINICAL POLICY DEPARTMENT: Medical

Opioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016

Have approved and decreed: Chapter 1 Definitions

Behind the Prescriptions

Does tramadol test positive

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse

NBPDP Drug Utilization Review Process Update

Drug-Related Deaths in Yolo County,

7/17/2017. FSHP 2017 ANNUAL MEETING Nothing to disclose. Opioid Overuse: National Epidemic. Opioid Epidemic: CDC Data

User Guide for Transition to the Drug Information System

A Bill Regular Session, 2015 SENATE BILL 717

AETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization

OxyContin in the 90 days prior to it being discontinued.

BC Methadone Maintenance System: Performance Measures 2011/2012 Appendix A: Report Figures and Data

Measure Summary: The opioid equivalency measure examines opioid administration for patients who undergo a surgical procedure.

Opioid Epidemic as it Relates to Counties

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory

Appendix 3: Taking controlled and prescription drugs to other countries

Safe Management of Controlled Drugs

ARKANSAS DEPARTMENT OF HEALTH

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Prior Authorization for Opioid Products Indicated for Pain Management

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

The Opioid Crisis And The New HQO Opioid Prescribing for Acute Pain Quality Standard. Lakehead Summer School 2018

MINISTRY REPONSE TO THE ONTARIO CITIZENS COUNCIL REPORT: INFORMING THE DEVELOPMENT OF A NEW DRUG PROGRAM IN ONTARIO

BC Coroners Service Prescription Opiate-Related Overdose Deaths

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Controlled Substances: A survey of tools and resources required by hospital pharmacists

Key points. Background

Access to pain therapy in the UN resolutions: worldwide perspective

SCG1 Evaluation of High Risk Pain Medications for MME

Recognizing Narcotic Abuse and Addiction and Helping Those With It

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT

Trends in Opioid Analgesic Abuse and Mortality in Europe

Drug Overdose Deaths St. Louis County, Missouri

Cigna Drug and Biologic Coverage Policy

Surveillance of Apparent Opioid Overdoses in New Brunswick

Cross allergies with codeine

Transcription:

May, 2017 9 Million Prescriptions: What we know about the growing use of prescription opioids in Ontario Technical Appendix May 8, 2017

Table of Contents Introduction... 3 Data Sources... 3 Narcotics Monitoring System, Ministry of Health and Long-Term Care... 3 Population estimates, Ministry of Finance... 3 Corporate Provider Database, Ministry of Health and Long-Term Care... 3 List of Opioids... 4 List of Short-Acting (immediate release) Opioids... 4 List of Long-Acting Opioids... 4 Methods... 5 Prescribers... 5 People who filled an opioid prescription (recipients)... 5 Number of people who filled an opioid prescription... 5 Rate of people who filled an opioid prescription (per 100 population)... 5 Opioid prescriptions filled (dispenses)... 6 Number of opioid prescriptions filled... 6 Rate of opioid prescriptions filled (per 100 population)... 6 One-time, short-term prescriptions... 7 Proportion of people who filled a prescription for a one-time, short-term prescription for an immediate-release opioid drug... 7 Analysis and Data Acknowledgements... 8 2 9 Million Prescriptions Health Quality Ontario

Introduction Health Quality Ontario has produced a report describing opioid prescribing in Ontario, specifically how many opioid prescriptions are filled, who receives opioid prescriptions, whether there is regional variation in the province, and the types of opioids that are being prescribed. This document is the technical appendix to 9 Million Prescriptions, released May 2017. The technical appendix provides a description of the methodology used to determine the numbers and rates per population of people who filled an opioid prescription (recipients) and of opioid prescriptions filled (dispenses), the number of opioid prescribers, and the proportion of filled prescriptions for oneoff opioid prescriptions for a short duration. A description of each data source is included in this appendix, as well as a list of the short-acting and long-acting opioid drugs considered in the analysis of this report. For more information, please contact us at SystemPerformance@HQOntario.ca Data Sources Narcotics Monitoring System, Ministry of Health and Long-Term Care The Narcotics Monitoring System (NMS) is a transaction-based system that collects dispensing data on opioids, controlled substances, and other monitored drugs from pharmacies and other dispensaries across Ontario, irrespective of whether the prescription is paid for under a publicly funded drug program, through private insurance, or by cash. The information collected in the NMS includes fields for prescriber identification, patient identification, pharmacy and pharmacist identification, date the drug was dispensed, drug identification number and the amount of drug dispensed. The NMS does not include information about monitored drugs dispensed to in-patients of public hospitals as part of their treatment, but it does include information about dispenses to out-patients of public hospitals and in-patients of private hospitals and healthcare facilities such as long-term care homes. Also, the NMS does not include information about monitored drugs dispensed to prisoners or inmates (i.e., prescriptions written for people confined to correctional institutions, penitentiaries, prisons or youth custody facilities). The Ministry of Health and Long-Term Care maintains the NMS, which was implemented in April 2012, became operational in May 2012 and is refreshed on a monthly basis. The data used in this report were extracted December 2016. Population estimates, Ministry of Finance The Ministry of Finance provides population estimates for the province and for each Local Health Integration Network (LHIN) region. The Ministry of Finance uses the most recent Statistics Canada population estimates by census subdivision as the base for the LHIN region population projections. The method of allocating a census sub-division to LHIN regions varies depending on the geographic makeup of the LHIN region but areas are consistently assigned to LHINs over time. The estimates used in this report were accessed December 2016. Corporate Provider Database, Ministry of Health and Long-Term Care The Corporate Provider Database (CPDB) is a repository of healthcare provider data. The CPDB contains information on the provider s birth date, gender, graduation date, reported specialties and postal code of practice. The Ministry of Health and Long-Term Care maintains the CPDB, with the College of Physicians and Surgeons of Ontario providing regular updates on provider credentials. The data used in this report were extracted December 2016. Health Quality Ontario 9 Million Prescriptions 3

List of Opioids List of Short-Acting (immediate release) Opioids List of Long-Acting Opioids Alfentanil Buprenorphine Butorphanol Codeine Codeine Fentanyl Codeine & acetaminophen Hydromorphone Codeine & acetylsalicylic acid Methadone Codeine, acetaminophen & caffeine Morphine Codeine, acetaminophen & chlorzoxazone Oxycodone Codeine, acetaminophen & doxylamine Oxycodone & naloxone Codeine, acetaminophen & methocarbamol Tapentadol Codeine, acetaminophen, chlorpheniramine & Tramadol pseudoephedrine Codeine, acetylsalicylic acid & caffeine Codeine, acetylsalicylic acid & methocarbamol Codeine, acetylsalicylic acid, caffeine & butalbital Codeine, acetylsalicylic acid, caffeine & meprobamate Codeine, brompheniramine, phenylephrine Codeine, pseudoephedrine & guaifenesin Codeine, pseudoephedrine & triprolidine Dextromethorphan Fentanyl Hydrocodone Hydrocodone & phenylephrine Hydrocodone & phenyltoloxamine Hydrocodone, etafedrine, doxylamine & sodium citrate Hydrocodone, pseudoephedrine & chlorpheniramine Hydrocodone, pyrilamine, phenylephrine & ammonium chloride Hydromorphone Ketamine Merperidine Morphine Morphine & Lidocaine Nalbuphine Normethadone & p-hydroxyephedrine Opium & belladonna Opium derivatives & expectorants Oxycodone Oxycodone & acetaminophen Oxycodone & acetylsalicylic acid Pentazocine Pethidine Remifentanil Sufentanil Tapentadol Tramadol Tramadol & acetaminophen 4 9 Million Prescriptions Health Quality Ontario

Methods Most of the results presented in the report are by fiscal year, meaning that data from April 1 of one year to March 31 of the next year are used in the calculation. Prescribers The number of healthcare professionals who prescribed opioids is a count of the number of health care professionals in Ontario who prescribed at least one of the opioids listed on the previous page (page 4) within the fiscal year. This number excludes prescribers who only prescribed methadone maintenance treatment (MMT) or buprenorphine/naloxone during this period. People who filled an opioid prescription (recipients) The number of people who filled an opioid prescription (recipients) is the count of the number of people for whom an opioid was dispensed during a one year period between April 1 and March 31. We did not count people who only filled prescriptions for MMT or buprenorphine/naloxone, however, if an individual was dispensed either of these treatments and also dispensed another opioid from the list on page 4, then they would be counted as having filled an opioid prescription. Number of people who filled an opioid prescription Count of the number of people who filled an opioid prescription in a given fiscal year People who were only dispensed methadone maintenance treatment or buprenorphine/naloxone The rates of opioid recipients (people who filled an opioid prescription) were calculated by dividing the count of the number of recipients by the estimated number of people in the province or LHIN region for the given fiscal year, and expressed using a 100 population denominator. Rate of people who filled an opioid prescription (per 100 population) The rate of the number of people who filled an opioid prescription per 100 people in the population in a given fiscal year Numerator: Count of the number of people who filled an opioid prescription in a given fiscal year People who were only dispensed methadone maintenance treatment or buprenorphine/naloxone Denominator: Number of people in the population Health Quality Ontario 9 Million Prescriptions 5

The report describes the number and rate for Ontario and the rate for the 14 LHIN regions. The LHIN region is determined according to the LHIN where the recipient resides. The report also describes the number, rate, and proportion of recipients by sex (male/female) and age group (0-18, 19-44, 45-64, 65+) of the person who filled an opioid prescription, as well as by type of opioid drug dispensed. Age was calculated from the first day of the fiscal year (April 1). Opioid prescriptions filled (dispenses) The number of opioid prescriptions filled (dispenses) is the count of the number of opioid dispenses during a one year period between April 1 and March 31. Prescriptions filled for MMT or buprenorphine/naloxone were not included. Number of opioid prescriptions filled Count of the number of opioid prescriptions filled in a given fiscal year Dispenses for methadone maintenance treatment or buprenorphine/naloxone The rates of opioid prescriptions filled were calculated by dividing the count of the number of prescriptions filled by the estimated number of people in the province or LHIN region for the given fiscal year, and expressed using a 100 population denominator. Rate of opioid prescriptions filled (per 100 population) The rate of the opioid prescriptions filled per 100 people in a given fiscal year Numerator: Count of the number of opioid prescriptions filled in a given fiscal year Dispenses for methadone maintenance treatment or buprenorphine/naloxone Denominator: Number of people in the population The report describes the number and rate for Ontario and the rate for the 14 LHIN regions. The LHIN region is determined according to the LHIN where the person who filled the opioid prescription resides. 6 9 Million Prescriptions Health Quality Ontario

One-time, short-term prescriptions In order to understand the proportion of one-time, short-term prescriptions among opioid recipients, we looked among all recipients during a three-month period to identify the number of people who filled a single prescription for an immediate-release drug with a supply of 14 days or less. We looked back one year and forward six months to confirm that the recipient had not filled another prescription during these periods. Proportion of people who filled a prescription for a one-time, short-term prescription for an immediate-release opioid drug Numerator (subset of the denominator): Number of people who had a single prescription filled for an immediate-release opioid drug with a supply of 14 days or less in the first three months of 2016 Recipients who had a single dispense only for an immediaterelease/short-acting opioid with a supply of 14 days or less in the period from January to March 2016 Recipients with any opioid dispense in the previous 12 months (January to December 2015) Recipients with any opioid dispense in the subsequent 6 months (April to September 2016) Denominator: Number of people who had at least one opioid prescription filled in the first three months of 2016 Recipients of at least one short-acting or long-acting opioid in the period from January to March 2016 Recipients who only had a single dispense or multiple dispenses for methadone maintenance therapy or buprenorphine/naloxone from January to March 2016 The report describes the proportion of people who filled an opioid prescription that was for a one-time prescription for a short-term, immediate-release opioid in Ontario by age group (0-18, 19-44, 45-64, 65+) of the person who filled an opioid prescription. Age was calculated from the first day of the fiscal year (April 1). Health Quality Ontario 9 Million Prescriptions 7

Analysis and Data Acknowledgements This report was developed by a multi-disciplinary team from Health Quality Ontario, including Susan Brien, Naushaba Degani, Maaike de Vries, Gail Dobell, Ryan Alexander Emond, Louise Grenier, Wissam Haj-Ali, Michal Kapral, Jonathan Lam, Binil Tahlan and Tommy Tam. Health Quality Ontario thanks the following people for their thoughtful input on the analysis plan and review of the data: Debika Burman, Senior Health Analyst at the Ministry of Health and Long-Term Care; and Tara Gomes, co-principal Investigator, Diana Martins, Senior Epidemiologist, and Mina Tadrous, Research Associate, with the Ontario Drug Policy Research Network. Health Quality Ontario also acknowledges the Health Analytics Branch of the Ministry of Health and Long-Term Care who provided reviews and data for the report. 8 9 Million Prescriptions Health Quality Ontario